


Christophe wrote:The face at an angle, another fucked checker who hasn't cleared?![]()
![]()
On December 19, I gave you the 17 studies found in the world, concerning ivermectin in prophylaxis, we can now add an 18th, more French. First in a western country, and “gold standard”. Curious to see the reactions of the ivermectin critics.
Medincell has just completed its SAIVE, randomized, double-blind, placebo-controlled study (NCT 05305560), aimed at protecting contact cases. The study of 399 participants reduced infections in the treated group by 72%.
His press release:
The SAIVE trial (NCT 05305560) is a Phase 2, multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical study evaluating the safety and efficacy of ivermectin taken orally for 28 days, under the supervision of an independent data monitoring committee based in the United States.
The study was conducted in Bulgaria between March and November 2022.
All participants were unvaccinated adults who had been exposed to the virus in the 5 days prior to their inclusion in the study, through direct and documented contact with a person diagnosed positive for SARS-CoV-2 by an RT-PCR test.
Participants included in the ivermectin group showed a statistically very significant reduction (72%) in the rate of laboratory-confirmed infections between the 1st and the 28th day (30/200), compared to the placebo group (105/199), with a p-value less than 0,0001 (p<0,0001). This was the primary endpoint of the study.
No safety signal linked to the daily intake of ivermectin, 200 micrograms/kg on the first day then 100 micrograms/kg per day from day 2 to day 28, was identified during the study.
The company plans to share the final analysis of the study, in a peer-reviewed publication, at a later date.
“The SAIVE study provides encouraging data demonstrating the efficacy and safety of ivermectin for the prevention of Covid-19 infection after exposure to the virus. It supports the development of a long-acting injectable, said Christophe Douat, CEO of MedinCell. Such a long-acting injectable could be a complementary tool in the fight against Covid-19. Several ivermectin formulations are ready for clinical batch manufacturing to begin regulatory preclinical and clinical development. We will define our strategy in the light of this first result and the complete analysis to come from the study. »
excerpt from the blog of the interested partyreinoso wrote:if he is allergic to HCQ zizi can jump on ivermectin without any risk
https://actu.fr/provence-alpes-cote-d-a ... 31681.htmlCovid-19. We followed for you the "antivax congress" sponsored by Didier Raoult in Marseille.
The symposium continues with the appearance of Gérard Maudrux, former doctor now prosecuted by the Order of Physicians. The man is known to promote another controversial drug against Covid-19: ivermectin
The former doctor intervenes by videoconference. The reason ? He delivered it in the preamble: “sorry not to be there. Unfortunately, it was Omicron who decided otherwise. And if I had come, imagine the press…”
Gérard Maudrux then launched into a tirade based on "cocorico"
Obamot wrote:Izy reminds me exactly of those mediocrities of a bygone era, who waited for the weekend to rush on the boulevard press (with a high index of gossip and beliefs of all kinds) "Paris here or "France Sunday" and other scandal press...
and it is a specialist in mediocrity who affirms that! Another self-proclaimed expert!You are lucky enough to be a mediocre who does not need to wait until the end of the week to rush to any rotten source. This is progress!
izentrop wrote:We knew it for a long time except the conspiracies![]()
Christophe wrote:Therefore ???
Back to "Health and Prevention. Pollution, causes and effects of environmental risks "
Users browsing this forum : Janic and 161 guests